Severe dysgeusia and weight loss associated with terbinafine use: A case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 42257155.
- Also identified by DOI 10.4103/jfmpc.jfmpc_144_26 and PMC identifier 13241104.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Terbinafine is a widely used antifungal agent, with dysgeusia recognized as an uncommon and typically self-limited adverse effect. Severe or prolonged taste disturbance is exceedingly rare. We report the case of a 72-year-old woman who developed profound dysgeusia shortly after initiation of oral terbinafine for onychomycosis, manifesting as a persistent metallic taste, marked aversion to sweet foods, anorexia, and progressive unintentional weight loss. Despite early discontinuation of terbinafine, symptoms progressed, leading to electrolyte abnormalities and significant functional decline and prompting an extensive diagnostic evaluation to exclude malignancy and other serious etiologies. Supportive management following drug cessation resulted in gradual but incomplete recovery over several months. This case demonstrates that terbinafine-associated dysgeusia may be severe, prolonged, and clinically consequential in older adults, emphasizing the need for early recognition and prompt discontinuation to mitigate morbidity.